{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T12:33:14Z","timestamp":1659097994739},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2010,12,18]],"date-time":"2010-12-18T00:00:00Z","timestamp":1292630400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1007\/s10157-010-0391-z","type":"journal-article","created":{"date-parts":[[2010,12,17]],"date-time":"2010-12-17T05:11:11Z","timestamp":1292562671000},"page":"289-293","source":"Crossref","is-referenced-by-count":5,"title":["Steroid treatment in patients with membranous nephropathy and hepatitis\u00a0B virus surface antigenemia: a report of two cases"],"prefix":"10.1007","volume":"15","author":[{"given":"Tetsu","family":"Akimoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiya","family":"Otake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideaki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiko","family":"Higashizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuhiko","family":"Nishino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamu","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norio","family":"Isoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeaki","family":"Muto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Sugano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiji","family":"Kusano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,12,18]]},"reference":[{"key":"391_CR1","first-page":"205","volume-title":"Heptinstall\u2019s pathology of the kidney","author":"MM Schwartz","year":"2007","unstructured":"Schwartz MM. Membranous nephropathy. In: Jennete JC, Olson JL, Schwartz MM, Silvia FG, editors. Heptinstall\u2019s pathology of the kidney. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2007. p. 205\u201351.","edition":"6"},{"key":"391_CR2","first-page":"268","volume":"20","author":"C Ponticelli","year":"2007","unstructured":"Ponticelli C. Membranous nephropathy. J Nephrol. 2007;20:268\u201387.","journal-title":"J Nephrol"},{"key":"391_CR3","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1159\/000185802","volume":"54","author":"KN Lai","year":"1990","unstructured":"Lai KN, Tam JS, Lin HJ, Lai FMM. The therapeutic dilemma of the usage of corticosteroid in patients with membranous nephropathy and persistent hepatitis\u00a0B virus surface antigenaemia. Nephron. 1990;54:12\u20137.","journal-title":"Nephron"},{"key":"391_CR4","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1111\/j.1523-1755.2005.00591.x","volume":"68","author":"S Tang","year":"2005","unstructured":"Tang S, Lai FMM, Lui YH, Tang CCO, Kung NNS, Ho YW, et al. Lamivudine in hepatitis\u00a0B-associated membranous nephropathy. Kidney Int. 2005;68:1750\u20138.","journal-title":"Kidney Int"},{"key":"391_CR5","doi-asserted-by":"crossref","first-page":"423","DOI":"10.5414\/CNP65423","volume":"65","author":"T Kobayashi","year":"2006","unstructured":"Kobayashi T, Ando Y, Umino T, Miyata Y, Muto S, Hironaka Y, et al. Complete remission of minimal-change nephrotic syndrome induced by apheresis monotherapy. Clin Nephrol. 2006;65:423\u20136.","journal-title":"Clin Nephrol"},{"key":"391_CR6","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1093\/ndt\/gfl108","volume":"21","author":"Y Nishioka","year":"2006","unstructured":"Nishioka Y, Horita Y, Tadokoro M, Taura K, Suyama N, Miyazaki M, et al. Changing mizoribine administration from three divided dose to one single dose induced remission of relapsed membranous nephropathy. Nephrol Dial Transplant. 2006;21:2337\u20138.","journal-title":"Nephrol Dial Transplant"},{"key":"391_CR7","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1159\/000077065","volume":"24","author":"R Bhimma","year":"2004","unstructured":"Bhimma R, Coovadia HM. Hepatitis\u00a0B virus-associated nephropathy. Am J Nephrol. 2004;24:198\u2013211.","journal-title":"Am J Nephrol"},{"key":"391_CR8","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0929-6646(08)60054-6","volume":"106","author":"TW Chuang","year":"2007","unstructured":"Chuang TW, Hung CH, Huang SC, Lee CM. Complete remission of nephrotic syndrome of hepatitis\u00a0B virus-associated membranous glomerulopathy after lamivudine monotherapy. J Formos Med Assoc. 2007;106:869\u201373.","journal-title":"J Formos Med Assoc"},{"key":"391_CR9","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1136\/ard.2005.043257","volume":"65","author":"LH Calabrese","year":"2006","unstructured":"Calabrese LH, Zein NN, Vassilopoulos D. Hepatitis\u00a0B virus (HBV) reactivation with immunosuppressive therapy in rheumatic diseases: assessment and preventive strategies. Ann Rheum Dis. 2006;65:983\u20139.","journal-title":"Ann Rheum Dis"},{"key":"391_CR10","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/j.1365-2141.2006.06465.x","volume":"136","author":"G Lalazar","year":"2007","unstructured":"Lalazar G, Rund D, Shouval D. Screening, prevention and treatment of viral hepatitis\u00a0B reactivation in patients with haematological malignancies. Br J Haematol. 2007;136:699\u2013712.","journal-title":"Br J Haematol"},{"key":"391_CR11","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1056\/NEJM199105233242103","volume":"324","author":"KN Lai","year":"1991","unstructured":"Lai KN, Li PKT, Lui SF, Au TC, Tam JSL, Tong KL, et al. Membranous nephropathy related to hepatitis\u00a0B virus in adults. N Eng J Med. 1991;324:1457\u201363.","journal-title":"N Eng J Med"},{"key":"391_CR12","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/hep.1840160104","volume":"16","author":"CK Chou","year":"1992","unstructured":"Chou CK, Wang LH, Lin HM, Chi CW. Glucocorticoid stimulates hepatitis\u00a0B viral gene expression in cultured human hepatoma cells. Hepatology. 1992;16:13\u20138.","journal-title":"Hepatology"},{"key":"391_CR13","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1155\/2005\/378587","volume":"19","author":"SI Gan","year":"2005","unstructured":"Gan SI, Devlin SM, Scott-Douglas NW, Burak KW. Lamivudine for the treatment of membranous glomerulopathy secondary to chronic hepatitis\u00a0B infection. Can J Gastroenterol. 2005;19:625\u20139.","journal-title":"Can J Gastroenterol"},{"key":"391_CR14","doi-asserted-by":"crossref","first-page":"53","DOI":"10.5414\/CNP65053","volume":"65","author":"C Okuse","year":"2006","unstructured":"Okuse C, Yotsuyanagi H, Yamada H, Ikeda H, Takahashi H, Suzuki M, et al. Successful treatment of hepatitis\u00a0B virus associated membranous nephropathy with lamivudine. Clin Nephrol. 2006;65:53\u20136.","journal-title":"Clin Nephrol"},{"key":"391_CR15","doi-asserted-by":"crossref","first-page":"208","DOI":"10.5414\/CNP65208","volume":"65","author":"N Kannaan","year":"2006","unstructured":"Kannaan N, Horsmans Y, Goffin E. Lamivudine for nephrotic syndrome related to hepatitis\u00a0B virus (HBV) infection. Clin Nephrol. 2006;65:208\u201310.","journal-title":"Clin Nephrol"},{"key":"391_CR16","doi-asserted-by":"crossref","first-page":"69","DOI":"10.5414\/CNP70069","volume":"70","author":"M Mesquita","year":"2008","unstructured":"Mesquita M, Lasser L, Langlet P. Long-term (7-year-) treatment with lamivudine monotherapy in HBV-associated glomerulonephritis. Clin Nephrol. 2008;70:69\u201371.","journal-title":"Clin Nephrol"},{"key":"391_CR17","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2169\/internalmedicine.47.0464","volume":"47","author":"T Masuda","year":"2008","unstructured":"Masuda T, Akimoto T, Ando Y, Kobayashi T, Meguro D, Muto S, et al. Changes in the urinary excretion of \u03b22-microglobulin (\u03b22MG) and N-acetyl- \u03b2-D-glucosaminidase (NAG) during treatment for lupus nephritis. Intern Med. 2008;47:287\u201390.","journal-title":"Intern Med"},{"key":"391_CR18","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/hep.21513","volume":"45","author":"ASF Lok","year":"2007","unstructured":"Lok ASF, McMahon BJ. Chronic hepatitis\u00a0B. Hepatology. 2007;45:507\u201339.","journal-title":"Hepatology"},{"key":"391_CR19","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1046\/j.1365-2893.2003.00479.x","volume":"11","author":"R Idilman","year":"2004","unstructured":"Idilman R, Arat M, Soydan E, T\u00f6r\u00fcner M, Soykan I, Akubulut H, et al. Lamivudine prophylaxis for prevention of chemotherapy-induced hepatitis\u00a0B virus reactivation in hepatitis\u00a0B virus carriers with malignancies. J Viral Hepatitis. 2004;11:141\u20137.","journal-title":"J Viral Hepatitis"},{"key":"391_CR20","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1053\/j.ajkd.2004.05.020","volume":"44","author":"A Perma","year":"2004","unstructured":"Perma A, Chieppati A, Zamora J, Giuliano GA, Braun N, Remuzzi G. Immunosuppressive treatment for idiopathic membranous nephropathy: a systematic review. Am J Kidney Dis. 2004;44:385\u2013401.","journal-title":"Am J Kidney Dis"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-010-0391-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10157-010-0391-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-010-0391-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T10:44:27Z","timestamp":1559126667000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10157-010-0391-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12,18]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["391"],"URL":"https:\/\/doi.org\/10.1007\/s10157-010-0391-z","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12,18]]}}}